176 related articles for article (PubMed ID: 34607478)
1. Co-delivery of sorafenib and crizotinib encapsulated with polymeric nanoparticles for the treatment of
Zhong T; Liu X; Li H; Zhang J
Drug Deliv; 2021 Dec; 28(1):2108-2118. PubMed ID: 34607478
[TBL] [Abstract][Full Text] [Related]
2. Polymer-based nanoparticles for chemo/gene-therapy: Evaluation its therapeutic efficacy and toxicity against colorectal carcinoma.
Chen Y; Li N; Xu B; Wu M; Yan X; Zhong L; Cai H; Wang T; Wang Q; Long F; Jiang G; Xiao H
Biomed Pharmacother; 2019 Oct; 118():109257. PubMed ID: 31377472
[TBL] [Abstract][Full Text] [Related]
3. Transferrin receptor-targeted HMSN for sorafenib delivery in refractory differentiated thyroid cancer therapy.
Ke Y; Xiang C
Int J Nanomedicine; 2018; 13():8339-8354. PubMed ID: 30584304
[TBL] [Abstract][Full Text] [Related]
4. Sorafenib Loaded Inhalable Polymeric Nanocarriers against Non-Small Cell Lung Cancer.
Shukla SK; Kulkarni NS; Farrales P; Kanabar DD; Parvathaneni V; Kunda NK; Muth A; Gupta V
Pharm Res; 2020 Mar; 37(3):67. PubMed ID: 32166411
[TBL] [Abstract][Full Text] [Related]
5. Co-drug delivery of regorafenib and cisplatin with amphiphilic copolymer nanoparticles: enhanced
Zhou Z
Drug Deliv; 2020 Dec; 27(1):1319-1328. PubMed ID: 32936009
[TBL] [Abstract][Full Text] [Related]
6. Precise engineering of hybrid molecules-loaded macromolecular nanoparticles shows
Liu D; Zhang W; Liu X; Qiu R
Drug Deliv; 2021 Dec; 28(1):776-786. PubMed ID: 33866910
[TBL] [Abstract][Full Text] [Related]
7. Decreasing acute toxicity and suppressing colorectal carcinoma using Sorafenib-loaded nanoparticles.
Li N; Chen Y; Sun H; Huang T; Chen T; Jiang Y; Yang Q; Yan X; Wu M
Pharm Dev Technol; 2020 Jun; 25(5):556-565. PubMed ID: 31958240
[No Abstract] [Full Text] [Related]
8. Paclitaxel-loaded poly(glycolide-co-ε-caprolactone)-b-D-α-tocopheryl polyethylene glycol 2000 succinate nanoparticles for lung cancer therapy.
Zhao T; Chen H; Dong Y; Zhang J; Huang H; Zhu J; Zhang W
Int J Nanomedicine; 2013; 8():1947-57. PubMed ID: 23696703
[TBL] [Abstract][Full Text] [Related]
9. Design of polyaspartic acid peptide-poly (ethylene glycol)-poly (ε-caprolactone) nanoparticles as a carrier of hydrophobic drugs targeting cancer metastasized to bone.
Liu J; Zeng Y; Shi S; Xu L; Zhang H; Pathak JL; Pan Y
Int J Nanomedicine; 2017; 12():3561-3575. PubMed ID: 28507436
[TBL] [Abstract][Full Text] [Related]
10. Co-delivery of cisplatin and paclitaxel by folic acid conjugated amphiphilic PEG-PLGA copolymer nanoparticles for the treatment of non-small lung cancer.
He Z; Huang J; Xu Y; Zhang X; Teng Y; Huang C; Wu Y; Zhang X; Zhang H; Sun W
Oncotarget; 2015 Dec; 6(39):42150-68. PubMed ID: 26517524
[TBL] [Abstract][Full Text] [Related]
11. Paclitaxel-loaded polymeric nanoparticles combined with chronomodulated chemotherapy on lung cancer: In vitro and in vivo evaluation.
Hu J; Fu S; Peng Q; Han Y; Xie J; Zan N; Chen Y; Fan J
Int J Pharm; 2017 Jan; 516(1-2):313-322. PubMed ID: 27884713
[TBL] [Abstract][Full Text] [Related]
12. Efficient delivery of antitumor drug to the nuclei of tumor cells by amphiphilic biodegradable poly(L-aspartic acid-co-lactic acid)/DPPE co-polymer nanoparticles.
Han S; Liu Y; Nie X; Xu Q; Jiao F; Li W; Zhao Y; Wu Y; Chen C
Small; 2012 May; 8(10):1596-606. PubMed ID: 22411637
[TBL] [Abstract][Full Text] [Related]
13. Engineering of hybrid anticancer drug-loaded polymeric nanoparticles delivery system for the treatment and care of lung cancer therapy.
Zhao Y; Liu K; Li J; Liao J; Ma L
Drug Deliv; 2021 Dec; 28(1):1539-1547. PubMed ID: 34282705
[TBL] [Abstract][Full Text] [Related]
14. Novel free-paclitaxel-loaded redox-responsive nanoparticles based on a disulfide-linked poly(ethylene glycol)-drug conjugate for intracellular drug delivery: synthesis, characterization, and antitumor activity in vitro and in vivo.
Chuan X; Song Q; Lin J; Chen X; Zhang H; Dai W; He B; Wang X; Zhang Q
Mol Pharm; 2014 Oct; 11(10):3656-70. PubMed ID: 25208098
[TBL] [Abstract][Full Text] [Related]
15. Biodegradable core-shell nanoassemblies for the delivery of docetaxel and Zn(II)-phthalocyanine inspired by combination therapy for cancer.
Conte C; Ungaro F; Maglio G; Tirino P; Siracusano G; Sciortino MT; Leone N; Palma G; Barbieri A; Arra C; Mazzaglia A; Quaglia F
J Control Release; 2013 Apr; 167(1):40-52. PubMed ID: 23298613
[TBL] [Abstract][Full Text] [Related]
16. Co-delivery of sorafenib and metapristone encapsulated by CXCR4-targeted PLGA-PEG nanoparticles overcomes hepatocellular carcinoma resistance to sorafenib.
Zheng N; Liu W; Li B; Nie H; Liu J; Cheng Y; Wang J; Dong H; Jia L
J Exp Clin Cancer Res; 2019 May; 38(1):232. PubMed ID: 31151472
[TBL] [Abstract][Full Text] [Related]
17. Characterization of the Uptake Efficiency and Cytotoxicity of Tetrandrine-Loaded Poly(N-vinylpyrrolidone)-Block-Poly(ε-caprolactone) (PVP-b-PCL) Nanoparticles in the A549 Lung Adenocarcinoma Cell Line.
Xu H; Li X; Kong H; Zeng X; Jin Y; Qi Y; Wang H; Xie W
J Biomed Nanotechnol; 2016 Aug; 12(8):1699-707. PubMed ID: 29342348
[TBL] [Abstract][Full Text] [Related]
18. RGD peptide-modified, paclitaxel prodrug-based, dual-drugs loaded, and redox-sensitive lipid-polymer nanoparticles for the enhanced lung cancer therapy.
Wang G; Wang Z; Li C; Duan G; Wang K; Li Q; Tao T
Biomed Pharmacother; 2018 Oct; 106():275-284. PubMed ID: 29966971
[TBL] [Abstract][Full Text] [Related]
19. Preparation and characterization of parthenolide nanocrystals for enhancing therapeutic effects of sorafenib against advanced hepatocellular carcinoma.
Liang P; Wu H; Zhang Z; Jiang S; Lv H
Int J Pharm; 2020 Jun; 583():119375. PubMed ID: 32344021
[TBL] [Abstract][Full Text] [Related]
20. Improved chemotherapeutic efficacy of injectable chrysin encapsulated by copolymer nanoparticles.
Kim KM; Lim HK; Shim SH; Jung J
Int J Nanomedicine; 2017; 12():1917-1925. PubMed ID: 28331315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]